Efficacy of Gatifloxacin in Pneumococcal Respiratory Infection

Soejima, R.; Saito, A.
December 1999
Drugs;Dec1999 Supplement 2, Vol. 58 Issue 6, p280
Academic Journal
Analyzes the clinical and bacteriological profiles of gatifloxacin and levofloxacin in patients with pneumonia and chronic respiratory tract infections caused by Streptococcus pneumoniae. Patient and methods; Results and discussion.


Related Articles

  • Streptococcus pneumoniae: Frequency, Susceptibility, Clinical Features and Outcome at a Tertiary Care Hospital. Choudhry, Shehla; Khan, Ejaz A.; Raja, Nazar Ullah // Infectious Disease Journal of Pakistan;Jan2011, Vol. 20 Issue 1, p264 

    Introduction Streptococcus pneumoniae, a significant pathogen, causes mostly upper respiratory tract infections or invasive pneumococcal disease such as pneumonia, bacteraemia and meningitis in adults and children. Isolation of S. pneumoniae from clinical specimens is difficult and there is a...

  • Telithromycin. Barman Balfour, J.A.; Figgitt, D.P. // Drugs;Apr2001, Vol. 61 Issue 6, p815 

    â–´ Telithromycin is the first member of a new family of the macrolide-lincosamide-streptogramin-B (MLS) class of antimicrobials, the ketolides. It has a good spectrum of activity against respiratory pathogens, including penicillin- and erythromycin-resistant pneumococci, as well as...

  • Role of Non-conventional T Lymphocytes in Respiratory Infections: The Case of the Pneumococcus. Ivanov, Stoyan; Paget, Christophe; Trottein, François // PLoS Pathogens;Oct2014, Vol. 10 Issue 10, p1 

    Non-conventional T lymphocytes constitute a special arm of the immune system and act as sentinels against pathogens at mucosal surfaces. These non-conventional T cells (including mucosal-associated invariant T [MAIT] cells, gamma delta [γδ] T cells, and natural killer T [NKT] cells)...

  • Clinical cure rates in subjects treated with azithromycin for community-acquired respiratory tract infections caused by azithromycin-susceptible or azithromycin-resistant Streptococcus pneumoniae: analysis of Phase 3 clinical trial data. Zhanel, George G.; Wolter, Kevin D.; Calciu, Cristina; Hogan, Patricia; Low, Donald E.; Weiss, Karl; Karlowsky, James A. // Journal of Antimicrobial Chemotherapy (JAC);Oct2014, Vol. 69 Issue 10, p2835 

    Background Community-acquired respiratory tract infections (CARTI) are commonly caused by Streptococcus pneumoniae (SPN) and empirically treated with azithromycin. This study assessed clinical cure rates in azithromycin-treated subjects with CARTI caused by azithromycin-susceptible (Azi-S) or...

  • Fluoroquinolone-Resistant Streptococcus pneumoniae Associated with Levofloxacin Therapy. Urban, Carl; Rahman, Naim; Zhao, Xilin; Mariano, Noriel; Segal-Maurer, Sorana; Drlica, Karl; Rahal, James J. // Journal of Infectious Diseases;9/15/2001, Vol. 184 Issue 6, p794 

    Fluoroquinolone-resistant cultures of Streptococcus pneumoniae were isolated from 2 patients who were treated for pneumonia with levofloxacin. Nucleotide sequence analysis of bacterial DNA showed that the isolates contained mutations in both parC (DNA topoisomerase IV) and gyrA (DNA gyrase),...

  • Levofloxacin remains effective against respiratory infections. Volansky, Rob // Infectious Disease News;Jul2008, Vol. 21 Issue 7, p11 

    The article focuses on a study which found that levofloxavin is still an effective treatment against Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis. In this study, researchers conducted pulse-field gel electrophoresis on isolates with elevated levofloxacin minimum...

  • Fluoroquinolones induce the expression of patA and patB, which encode ABC efflux pumps in Streptococcus pneumoniae. El Garch, Farid; Lismond, Ann; Piddock, Laura J. V.; Courvalin, Patrice; Tulkens, Paul M.; Van Bambeke, Françoise // Journal of Antimicrobial Chemotherapy (JAC);Jun2011, Vol. 66 Issue 6, p1414 

    A correction to the article "Fluroquinolones Induce the Expression of patA and patB, Which Encode ABC Efflux Pumps in Streptococcus Pneumoniae," by Farid El Garch et al. that was published in the October 2010 issue is presented.

  • Failure of Treatment of Pneumonia Associated with Highly Resistant Pneumococci in a Child. Dowell, Scott F.; Smith, Tammy; Leversedge, Kimberly; Snitzer, Joseph // Clinical Infectious Diseases;8/1/1999, Vol. 29 Issue 2, p462 

    Presents a case of a failure of treatment of pneumonia associated with highly resistant pneumococci in an 18-month old boy. Laboratory findings; Description of the chest radiograph of the boy who was readmitted to a hospital due to pneumonia and bacteremia; Factors for the failure of initial...

  • More on drug resistance in the pneumococcus. Pinkowish, Mary Desmond // Patient Care;3/30/1996, Vol. 30 Issue 6, p17 

    Presents information on the administering of drugs to persons with streptococcus pneumoniae. Findings of study by Joseph F. Plouffe, MD, on streptococcus pneumoniae and antibiotic resistance in a county of Ohio; Where Dr. Plouffe works; Basis of the study; Examination of 590 patients with...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics